Health and Fitness

FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers

Silver Spring, Maryland—(ENEWSPF)—December 28, 2017

By: Stephanie Caccomo

Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.

“Diabetes is the leading cause of lower limb amputations,” said Binita Ashar, M.D., director of the division of surgical devices in FDA’s Center for Devices and Radiological Health. “The FDA is dedicated to making technologies available that can help improve the quality of life for those with chronic diseases. Additional options for successfully . . .

First Trustee Forum

First Mayoral Forum

Please follow & like us :)